Homocysteine-Lowering Therapy and Risk for Venous Thromboembolism

Figure 1. *Limited to the 3306 participants for whom homocysteine was measured at baseline. †Homocysteine level >13.8 µmol/L.
Figure 1. *Limited to the 3306 participants for whom homocysteine was measured at baseline. †Homocysteine level >13.8 µmol/L. Risk for venous thromboembolism (VTE) in prespecified subgroups.

This Article

  1. Published online before print April 30, 2007, Ann Intern Med June 5, 2007 vol. 146 no. 11 761-767
  1. AbstractFREE
  2. Figures
  3. Full Text
  4. Full Text (PDF)

Current Issue

  1. November 17, 2009, 151 (10)
  1. Alert me to current issues